What is CDTX's current stock price?

As of now, CDTX is trading at $217.70, with a daily change of +105.41%.

What are the risks associated with CDTX stock?

CDTX Key risk is its Extreme, .

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

CDTX Stock Analysis & IQ Rating | Cidara Therapeutics Inc.

CDTX

Cidara Therapeutics Inc.

$217.70

+$111.71 | +105.41%

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

alert Latest Updates

Top.Gainers 01:21 PM

Cidara Therapeutics is the headline mover of the day, soaring more than 105 percent after Merck confirmed a 9.2-billion-dollar acquisition that values the company at 221.50 dollars per share, a massive premium to its pre...

CDTX Stock IQ

Login to see Cidara Therapeutics Inc. (CDTX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

CDTX Target Price

Login to display

Strengths

CDTX Rewards

Upgraded on attractively valued

CDTX Rewards

Outperform the market

CDTX Rewards

Trading below its fair value

Risk Analysis

CDTX Risk Analysis

Earnings are forecast to decrease

Chart

$101.52 (+114.44%)

$67.49 (+222.57%)

$49.33 (+341.31%)

$20.2 (+977.72%)

1year

6month

3month

1month

CDTX Risk Level

CDTX has Extreme risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

High volatilty

Extreme

LOW

HIGH

CDTX Analysts Opinion

CDTX overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

CDTX Analysts Opinion

CDTX Analysts opinion is positive and also has improved from the past 3 months

CDTX Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential.

80%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

CDTX Street Sentiment

CDTX Street Sentiment is unimpressive and have negative views on the near-term outlook

CDTX Performance Sentiment

Sentiments overview associated with CDTX events and the stock performance.

80%

20%

Positive

Negative

12 out of 15
events present

3 out of 15
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$107.12

Resistance
Price

$87.01

Current Price Range

$113.05

Show methods +

CDTX Latest Analysis +

Legence Cidara Therapeutics Avadel Pharmaceuticals Omeros And Other Big Stocks Moving Higher On Friday. United States stocks were lower with the Dow Jones index falling more than 500 points on Friday.Shares of ) rose sharply during Friday'.s session after delivering mixed third-quarter results in its first earnings report since going public.The company posted revenue of $708.01 million up 26.2% year-over-year and ahead of analyst expectations of $639.78 million. Gross margin eased to 20.9% f

Today

$217.70 | +105.41%

Activity

Earnings

Momentum

Merck bets on flu prevention with $9.2 billion deal for Cidara Therapeutics. Merck will pay $221.50 per share in cash for Cidara the companies said on Friday a premium of 108.9% from its last closing price.

Today

$217.70 | +105.41%

Activity

Why RLX Technology Shares Are Trading Higher By 6%. Here Are 20 Stocks Moving Premarket. Shares of ) rose sharply in pre-market trading after the company reported financial results for the third quarter.RLX Technology reported quarterly earnings of 3 cents per share on $158.600 million in sales.RLX Technology shares jumped 6% to $2.47 in the pre-market trading session.Here are some other stocks moving in pre-market trading.) surged 92% to $203.50 in pre-market trading. A Schedule 13D Amendment N

Today

$217.70 | +105.41%

Potential

Merck bets on flu prevention with about $9.2 billion deal for Cidara Therapeutics.

Today

$217.70 | +105.41%

Activity

Why Is Cidara Therapeutics (CDTX) Stock Trending Overnight?. ) shares are trending on Friday.Check out the current price of .CDTX surged 42.23% in after-hours trading on Thursday closing at $150.75. A Schedule 13D Amendment No. 4 filed Nov. 10 showed that RA Capital Management L.P. along with The filing explicitly stated it was submitted “.to report the dilution of the Reporting Persons’. beneficial ownership in the Issuer’.s common stock and not as a result of any acquisition or

Today

$217.70 | +105.41%

Activity

Momentum

Cidara Therapeutics Shares Surge In After-Hours On Report Of Nearing Merck Deal . (RTTNews) - Merck & Co. Inc. (MRK) is nearing a deal to acquire Cidara Therapeutics (CDTX) a biotechnology company developing a long-acting antibody treatment for influenza the Financial Times reported citing people familiar with the matter.

Today

$217.70 | +105.41%

Activity

Commit To Buy Cidara Therapeutics At $70 Earn 24.3% Using Options. Investors eyeing a purchase of Cidara Therapeutics Inc (Symbol: CDTX) shares but cautious about paying the going market price of $106.57/share might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in parti

Tue Nov 11, 2025

$108.19 | +4.24%

Activity

Potential

Needham Maintains Cidara Therapeutics (CDTX) Buy Recommendation. Fintel reports that on November 7 2025 Needham maintained coverage of Cidara Therapeutics (NasdaqCM:CDTX) with a Buy recommendation. Analyst Price Forecast Suggests 70.10% Upside

Fri Nov 7, 2025

$104.39 | +5.83%

Rating

Cidara Therapeutics GAAP EPS of -$3.10 misses by $1.80.

Thu Nov 6, 2025

$98.64 | +1.02%

Earnings

FAQ About CDTX Stock Insights

What is CDTX current stock price?

What are CDTX stock strengths?

What risks are associated with CDTX stock?

When is CDTX next earnings report?

What is CDTX market cap and volume?

What is CDTX's current Stock IQ?

Should I buy CDTX stock right now?

Is CDTX a Strong Buy right now?

What does a 'Strong Buy' rating mean for CDTX?

What does a 'Strong Sell' rating mean for CDTX?

What factors influence CDTX's Stock IQ?

Explore our CDTX Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored CDTX Stock Strategies
Effective Risk Management

FIND US ON

Receive our CDTX Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

CDTX

Cidara Therapeutics Inc.

Current Price

$217.70

+$111.71 | +105.41%

52W High

$ 218.85

MKT CAP

$ 6.84B

52W Low

$ 13.9

VOL

$ 16.13M

P/E Ratio

N/A

AVG VOL

$ 898.13K

RSI

88.39

TREND

Uptrend

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

CDTX Rewards

Upgraded on attractively valued

CDTX Rewards

Outperform the market

CDTX Rewards

Trading below its fair value

Risk Analysis

CDTX Risk Analysis

Earnings are forecast to decrease

CDTX Stock IQ

Login to unlock Cidara Therapeutics Inc. (CDTX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Chart

$101.52 (+114.44%)

$67.49 (+222.57%)

$49.33 (+341.31%)

$20.2 (+977.72%)

1year

6month

3month

1month

CDTX Analysts Opinion

CDTX Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

CDTX Analysts Opinion

CDTX Analysts opinion is positive and also has improved from the past 3 months

CDTX Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential.

80%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

CDTX Street Sentiment

CDTX Street Sentiment is unimpressive and have negative views on the near-term outlook

CDTX Risk Level

CDTX has Extreme risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

High volatilty

Extreme

LOW

HIGH

CDTX Performance Sentiment

Sentiments overview associated with CDTX events and the stock performance.

80%

20%

Positive

Negative

12 out of 15
events present

3 out of 15
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$107.12

Resistance
Price

$87.01

Current Price Range

$113.05

Show methods +

CDTX Latest Analysis

Top.Gainers 01:21 PM

Cidara Therapeutics is the headline mover of the day, soaring more than 105 percent after Merck confirmed a 9.2-billion-dollar acquisition that values the company at 221.50 dollars per share, a massive premium to its pre...

Discover CDTX Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of CDTX. We're here to help you make informed investment decisions today.

FIND US ON

Receive our CDTX Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

CDTX Stock trends

CDTX Stock performance

CDTX Stock analysis

CDTX investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing CDTX

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing CDTX

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

CDTX Stock Analysis & IQ Rating | Cidara Therapeutics Inc.

CDTX Stock IQ

CDTX Target Price

CDTX Risk Level

CDTX Analysts Opinion

CDTX Street Sentiment

CDTX Performance Sentiment

Technical Price Levels

Explore our CDTX Stock insights

Receive our CDTX Daily Alerts

CDTX Stock IQ

CDTX Street Sentiment

CDTX Risk Level

Technical Price Levels

Discover CDTX Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of CDTX. We're here to help you make informed investment decisions today.

Receive our CDTX Daily Alerts

CDTX Runner Alarm